All eyes on Quidel earnings as estimates tumble, asset sale looms

Quidel Corporation is set to report its second-quarter earnings after market close on Thursday, August 6, 2026, with analysts anticipating a loss of 4 cents per share. Investor confidence has waned due to declining EPS estimates and uncertainty surrounding the potential $1.5 billion sale of its point-of-care testing business. Key concerns for investors include the strategic review, impact of China's policy changes on revenue, and growth in non-respiratory diagnostics.